Remove 2000 Remove Clinical Trials Remove Decriminalization Remove Treatment
article thumbnail

Which States Are Voting on Psychedelics?

Veriheal

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Johns Hopkins University first received regulatory approval for psychedelic research in the year 2000. Minnesota Rep. Missouri Rep.

article thumbnail

CBD is Everywhere – But Where Does the FDA Stand?

The Blunt Truth

The public hearing attracted over 100 speakers and 2000 participants. In each instance, the companies were selling products with flagrant disease-related claims that the FDA had not approved for the treatment or prevention of any ailments. In 2019, the FDA issued warning letters to four companies marketing and selling CBD products.

CBD 80
article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

there has never been a better time for new treatment options. Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick Doblin, Ph.D, in/rickdoblin/ [link]. in/andrewyangvfa/ [link].